Concentrated autologous bone marrow aspirate transplantation treatment for corticosteroid-induced osteonecrosis of the femoral head in systemic lupus erythematosus

Int Orthop. 2011 Jun;35(6):823-9. doi: 10.1007/s00264-010-1048-y. Epub 2010 May 29.

Abstract

The purpose of this study was to evaluate concentrated autologous bone marrow aspirate transplantation (CABMAT) treatment for corticosteroid-induced osteonecrosis of the femoral head (ONFH) in systemic lupus erythematosus (SLE). Bone marrow was aspirated from iliac crests, concentrated on a conventional manual blood bag centrifugation technique that is used to extract buffy coats and then injected into nine hips with drilling. The mean number of nucleated cells for transplantation was 5.32 × 10(7) cells/ml. This cell concentration was significantly higher after concentration, and the mean concentration ratio was 5.5. At follow-up (minimum: three years), significant improvement in pain and Harris Hip Score was observed. For eight of nine hips, we successfully preserved the femoral head. However, one hip required total hip arthroplasty 45 months after the operation. CABMAT using our centrifugation technique is an effective, safe and low-cost procedure of therapeutic osteogenesis for corticosteroid-induced ONFH in SLE.

MeSH terms

  • Adolescent
  • Adult
  • Bone Marrow Transplantation / methods*
  • Female
  • Femur Head Necrosis / chemically induced
  • Femur Head Necrosis / pathology*
  • Femur Head Necrosis / surgery
  • Glucocorticoids / adverse effects*
  • Humans
  • Lupus Erythematosus, Systemic / complications
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / surgery*
  • Middle Aged
  • Osteogenesis / physiology
  • Transplantation, Autologous
  • Treatment Outcome

Substances

  • Glucocorticoids